Sign In
Buy TMCI
$3.69
+0.290 (+8.53%)
At Close: Jun 04, 2026
LOS ANGELES, CA / ACCESSWIRE / November 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Wants Shareholders To Join An Inquiry Into Treace Medical Concepts Inc For Violating Securities Regulations
01:00pm, Saturday, 16'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
LOS ANGELES, CA / ACCESSWIRE / November 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
Treace Medical Concepts Inc Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Help The Schall Law Firm
12:00pm, Thursday, 14'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Invites Shareholders To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
11:15am, Wednesday, 13'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
Treace Medical Concepts Inc Is Being Investigated For Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm
12:00pm, Tuesday, 12'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm
03:30am, Tuesday, 12'th Nov 2024
LOS ANGELES , Nov. 12, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Conc
The Schall Law Firm Wants Shareholders To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
02:15pm, Monday, 11'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
Treace Medical Concepts Inc May Have Defrauded The Public And Investors With Losses Are Urged To Contact The Schall Law Firm
12:30pm, Sunday, 10'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medica
The Schall Law Firm Invites Stockholders To Join An Inquiry Into Treace Medical Concepts, Inc.'s Securities Law Violations
12:30pm, Saturday, 09'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
LOS ANGELES, CA / ACCESSWIRE / November 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations
11:00am, Thursday, 07'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
LOS ANGELES, CA / ACCESSWIRE / November 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical
Treace Medical Concepts, Inc. (TMCI) Q3 2024 Earnings Call Transcript
10:01pm, Tuesday, 05'th Nov 2024
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q3 2024 Earnings Call November 5, 2024 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations John Treace - Chief Executive Officer Mark Hai
Did Treace Medical Concepts, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate– TMCI
09:30pm, Tuesday, 05'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc.") (NASDAQ:TMC
